Hikal - Pharma & Agrochem

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with the circular no. SEBI/ HO/ CFD/ CFD-PoD-1/ P/ CIR/
2023/ 123 issued by SEBI on July 13, 2023, and further to the intimation sent by the Company on
July 23, 2023, we hereby wish to inform you that GPCB, vide communication dated August 5, 2023,
has revoked the closure direction dated July 21, 2023 issued by GPCB, for an initial period of 3
months, as per the procedure.

1 Like

More drama ! Don’t see any direct monetary repercussions but the sooner this gets resolved the better for Hikal, as it takes away the focus of the management and is an unnecessary distraction.

The management eluded questions on any clear guidance in Q2 FY 24. Took a cue from past, not to focus more on guidance. Viraj Mehta’s question were good. too which the management have had hardly any clear answers.

4 Likes

Highcourt has disposed of the writ petition, filed by the Company challenging the jurisdiction of the principal bench of NGT, as not maintainable and granted liberty to the Company to seek remedies as available under law.

Total financial liability will be around 18cr.

cbd10010-33e5-4d26-951c-123461aa356b.pdf (557.9 KB)